Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
01 03 2022
Historique:
pubmed: 22 12 2021
medline: 15 3 2022
entrez: 21 12 2021
Statut: ppublish

Résumé

22q11.2 deletion syndrome (22q11.2DS) is a genetic neurodevelopmental disorder that represents one of the greatest known risk factors for psychosis. Previous studies in psychotic subjects without the deletion have identified a dopaminergic dysfunction in striatal regions, and dysconnectivity of striatocortical systems, as an important mechanism in the emergence of psychosis. Here, we used resting-state functional MRI to examine striatocortical functional connectivity in 22q11.2DS patients. We used a 2 × 2 factorial design including 125 subjects (55 healthy controls, 28 22q11.2DS patients without a history of psychosis, 10 22q11.2DS patients with a history of psychosis, and 32 subjects with a history of psychosis without the deletion), allowing us to identify network effects related to the deletion and to the presence of psychosis. In line with previous results from psychotic patients without 22q11.2DS, we found that there was a dorsal to ventral gradient of hypo- to hyperstriatocortical connectivity related to psychosis across both patient groups. The 22q11.2DS was additionally associated with abnormal functional connectivity in ventral striatocortical networks, with no significant differences identified in the dorsal system. Abnormalities in the ventral striatocortical system observed in these individuals with high genetic risk to psychosis may thus reflect a marker of illness risk.

Identifiants

pubmed: 34931688
pii: 6472397
doi: 10.1093/schbul/sbab139
pmc: PMC8886597
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-494

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Front Neurol. 2017 Jul 17;8:323
pubmed: 28769862
Arch Gen Psychiatry. 1999 Oct;56(10):940-5
pubmed: 10530637
Curr Psychiatry Rep. 2008 Apr;10(2):148-57
pubmed: 18474208
Schizophr Res. 2019 Jun;208:353-359
pubmed: 30711314
Psychiatry Res Neuroimaging. 2021 Jan 30;307:111202
pubmed: 33046343
Neuropsychopharmacology. 2016 Apr;41(5):1274-85
pubmed: 26346637
Mol Psychiatry. 2021 May 12;:
pubmed: 33981004
Schizophr Res. 2017 Feb;180:48-57
pubmed: 27595552
Biol Psychiatry. 2010 Oct 1;68(7):625-33
pubmed: 20570244
PLoS One. 2011;6(9):e25031
pubmed: 21949842
Schizophr Bull. 1976;2(1):19-76
pubmed: 779020
Schizophr Bull. 1998;24(2):231-48
pubmed: 9613623
PLoS One. 2018 May 3;13(5):e0196503
pubmed: 29723244
Brain. 2017 May 1;140(5):1371-1383
pubmed: 28369257
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
JAMA Neurol. 2013 Nov;70(11):1359-66
pubmed: 24018986
Schizophr Bull. 2017 Oct 21;43(6):1240-1250
pubmed: 28575475
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Mov Disord Clin Pract. 2018 Nov 09;6(1):11-16
pubmed: 30746410
J Neurodev Disord. 2019 Jun 7;11(1):7
pubmed: 31174463
Hum Brain Mapp. 2008 Apr;29(4):478-89
pubmed: 17525988
Biol Psychiatry. 2008 Nov 1;64(9):758-65
pubmed: 18639238
Trends Neurosci. 2019 Mar;42(3):205-220
pubmed: 30621912
Sci Rep. 2017 May 11;7(1):1795
pubmed: 28496102
Dialogues Clin Neurosci. 2016 Mar;18(1):7-21
pubmed: 27069376
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
PLoS One. 2016 Nov 9;11(11):e0159928
pubmed: 27828960
Soc Cogn Affect Neurosci. 2012 Aug;7(6):738-42
pubmed: 22641837
J Child Psychol Psychiatry. 2016 Apr;57(4):446-56
pubmed: 26577292
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Neurology. 2018 Jun 5;90(23):e2059-e2067
pubmed: 29752303
Neuroimage. 2018 May 1;171:415-436
pubmed: 29278773
Neuropsychopharmacology. 2015 Feb;40(3):622-31
pubmed: 25141922
Am J Psychiatry. 2020 Jul 1;177(7):589-600
pubmed: 32046535
Schizophr Bull. 2014 Jul;40(4):904-13
pubmed: 23861539
Biol Psychiatry. 2019 Jul 1;86(1):16-24
pubmed: 30952359
Mol Psychiatry. 2014 Jan;19(1):37-40
pubmed: 24217254
Cereb Cortex. 2008 Dec;18(12):2735-47
pubmed: 18400794
Am J Hum Genet. 1997 Sep;61(3):620-9
pubmed: 9326327
Am J Med Genet. 1999 Oct 8;86(4):359-65
pubmed: 10494092
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
JAMA Psychiatry. 2013 Nov;70(11):1143-51
pubmed: 24005188
Neuroimage. 2015 May 15;112:267-277
pubmed: 25770991
Psychol Med. 2019 Apr;49(5):780-790
pubmed: 29897026
Nat Rev Neurosci. 2016 Aug;17(8):524-32
pubmed: 27256556
Schizophr Bull. 2009 May;35(3):549-62
pubmed: 19325164
Am J Psychiatry. 2011 Dec;168(12):1311-7
pubmed: 21768612
Nat Neurosci. 2005 Nov;8(11):1500-2
pubmed: 16234808

Auteurs

Ángeles Tepper (Á)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.

Analía Cuiza (A)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.

Luz María Alliende (LM)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.

Carlos Mena (C)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.
Division of Psychology and Language Sciences, University College London, London, UK.

Juan Pablo Ramirez-Mahaluf (JP)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.

Barbara Iruretagoyena (B)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.
Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.

Claudia Ornstein (C)

Hospital Clínico Universidad de Chile, Departamento de Psiquiatria y Salud Mental, Santiago, Chile.

Rosemarie Fritsch (R)

Hospital Clínico Universidad de Chile, Departamento de Psiquiatria y Salud Mental, Santiago, Chile.

Ruben Nachar (R)

Early Intervention Program, Instituto Psiquiátrico Dr J. Horwitz Barak, Santiago, Chile.
School of Medicine, Universidad Finis Terrae, Santiago, Chile.

Alfonso González-Valderrama (A)

Early Intervention Program, Instituto Psiquiátrico Dr J. Horwitz Barak, Santiago, Chile.
School of Medicine, Universidad Finis Terrae, Santiago, Chile.

Juan Undurraga (J)

Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Early Intervention Program, Instituto Psiquiátrico Dr J. Horwitz Barak, Santiago, Chile.

Juan Pablo Cruz (JP)

Department of Radiology, Pontificia Universidad Católica de Chile, Santiago, Chile.

Cristian Tejos (C)

Department of Electrical Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile.
Millennium Nucleus for Cardiovascular Magnetic Resonance, Santiago, Chile.
Biomedical Imaging Center, Pontificia Universidad Católica de Chile, Santiago, Chile.

Alex Fornito (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Melbourne, Australia.

Gabriela Repetto (G)

Genetic and Genomic Center, Universidad del Desarrollo, Santiago, Chile.

Nicolas Crossley (N)

Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile.
Millennium Nucleus for Cardiovascular Magnetic Resonance, Santiago, Chile.
Biomedical Imaging Center, Pontificia Universidad Católica de Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH